Aug 15, 2023 In the News BioGenerator Company Wugen Begins Phase 1 Clinical Trial of Allogeneic Memory Natural Killer (NK) Cell Therapy
May 18, 2023 In the News BioGenerator Company Immunophotonics Receives Green Light from FDA to Open IND
Mar 20, 2023 Press Releases BioGenerator Leads $2M Funding Round with Ospraie Ag Science to Scale Agragene.
Feb 6, 2023 In the News BioGenerator Company KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product
